Avista Therapeutics, a preclinical gene therapy company built on deep clinical, computational and gene therapy expertise, today announced the significant expansion of its gene therapy platform.

What is unfolding now is not merely a tactical disagreement over Yemen, but an expression of deeper strategic, economic, and ...

Most HR systems aren’t built to address impostor syndrome. They recognize burnout but not the cognitive load of chronic ...

In its Q3 FY26 defence sector results preview, the brokerage said the sector is transitioning from a policy-led induction ...

The government’s tax reforms will increase the disposable income of consumers while measures such as the Labour Codes will ...

Institutions moved away from Bitcoin in 2025 as altcoin ETFs gained attention, but weak fundamentals suggest the shift may ...

Ray Dalio's 2025 market review reveals dollar fell 39% vs gold while foreign investors fled U.S. assets. Midterm elections ...

Gilles de Greling, Palm Beach Director of Gander & White, analyzes how philanthropy has evolved from episodic generosity into ...

The results of 2025 indicate that Russia's industry has shifted into stagnation following a brief period of growth driven by ...

How layoffs, AI adoption and policy pressures reshaped workforce opportunity in 2025, revealing risks that leaders must ...

A genetic mutation passed from mother to children in families affected by schizophrenia has now been shown to completely ...

DUBAI, UAE, Jan. 6, 2026 /PRNewswire/ — Bybit, the world’s second-largest cryptocurrency exchange by trading volume, has ...